Expression of Ndst2, MPO, mMCP4 and mMCP6 correlated to the expression of miRNAs that potentially target these transcripts. by Yang Xiang (35912)

“…<p>(A) Expression levels of Ndst2, MPO, mMCP4 and mMCP6 were determined by qPCR. …”

N protein of SVCV inhibits p53 expression. by Shun Li (330132)

“…<p><b>(A)</b> SVCV infection decreases the expression of endogenous p53 protein. …”

Norbornyl Cations of Group 14 Elements by Thomas Müller (3554)

“…This points to a reduced electrophilicity of the plumbacation compared to its predecessors.…”

Function of <i>i</i>NKT cells in the spleen and liver from <i>Il17rb</i>^−/− and <i>Il15</i>^L117P mice. by Hiroshi Watarai (185010)

“…Cytokines were measured by ELISA or a cytometric bead array system at the indicated time points. …”

Mutations of SWI/SNF components and the small ribosomal subunit Rps2 result in elevated noise. by Shu-Ting You (140787)

“…Data associated with this figure can be found in the supplemental data file (<a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3000433#pbio.3000433.s009" target="_blank">S1 Data</a>). …”

Supplementary Material for: Na⁺-Leak Channel, Non-Selective (NALCN) Regulates Myometrial Excitability and Facilitates Successful Parturition by Reinl E.L. (5531735)

“…In human myometrium, the Na⁺ leak channel, non-selective (NALCN) contributes to a gadolinium-sensitive, Na⁺-dependent leak current. …”

Effect of EPO on Organ Function in <i>HS-65_BV+VP</i>. by Vesna Borovnik-Lesjak (653673)

“…*<i>p≤</i>0.05 and ^†<i>p≤</i>0.01 denote statistically significant differences between groups at the specified time points. ^a<i>p≤</i>0.05, ^b<i>p≤</i>0.01, and ^c<i>p≤</i>0.001 denote statistically significant differences <i>vs</i> baseline using the Holm-Sidak test for multiple comparisons showing the differences only when they occurred in one of the two groups.…”

Effects of CO₂ on diazotroph biomass δ¹⁵N by Dalin Shi (7966049)

“…Nitrogen isotope fractionation during this process is a key parameter for understanding the nitrogen cycle, however, relatively little is known about its regulatory mechanisms. …”

Gray matter alterations in the hippocampus and diffusion anisotropy with HYDI. by Madelaine Daianu (831026)

“…<p><b>A.</b> Transmission electron micrographs from 16 month old TgF344-AD rat hippocampus show numerous dystrophic neurites (DN, <i>left panel</i>), which are swollen at higher magnification (<i>right panel</i>). …”

CRAI with 5-Fu and Octreotide (Oct) attenuated serum parameters of pancreatitis. by Meng Tao Zhou (321534)

“…<p>Three treatment groups have lower serum levels of amylase activity, TNF-α and BUN as compared to the SAP group at different time points. The combined use of 5-Fu and Oct significantly decreased the levels of amylase activity as compared to single use of 5-Fu or Oct. …”

Knock-down of PGC-1α accelerated high glucose-induced VSMC proliferation and migration. by Lingyun Zhu (35902)

“…Effects of decreased PGC-1α on high glucose-induced VSMC proliferation were determined by cell counting (C). …”

Wnt/β-catenin signaling pathway activation in conjunctival epithelium of airlift explant cultures. by Hui Lin (161703)

“…<p>β-catenin (column A) and phosphor-β-catenin (Ser-552, column B) staining were performed at different time points after airlifting culture. β-catenin mostly anchored to the cell membrane and showed very low expression levels in cytoplasm of normal conjunctival epithelium (D0). …”

Detrended cumulative plots based on data for the human chromosome 6. by Dorota Mackiewicz (31938)

“…<p><b>A</b>. Distribution of recombination hotspots along the chromosome. …”

Data Sheet 1_Development of subjective well-being in adolescents before and during the COVID-19 pandemic.pdf by Helene Eckert (20639243)

“…Data from N = 207 students (Grade 5 to 9) from two German schools were assessed on four measurement time points, three before and one after the onset of the pandemic. …”

Data Sheet 3_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... by Alessandro Colletta (1509928)

“…Secondary outcomes included LS changes measured via TE and ARFI. Additional end points included MELD-Na, MELD 3.0, CTP scores, hepatic decompensations, proteinuria, body mass index (BMI), hemoglobin A1c (Hb-A1c), blood glucose (BG).…”

Data Sheet 1_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... by Alessandro Colletta (1509928)

“…Secondary outcomes included LS changes measured via TE and ARFI. Additional end points included MELD-Na, MELD 3.0, CTP scores, hepatic decompensations, proteinuria, body mass index (BMI), hemoglobin A1c (Hb-A1c), blood glucose (BG).…”

Data Sheet 8_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... by Alessandro Colletta (1509928)

“…Secondary outcomes included LS changes measured via TE and ARFI. Additional end points included MELD-Na, MELD 3.0, CTP scores, hepatic decompensations, proteinuria, body mass index (BMI), hemoglobin A1c (Hb-A1c), blood glucose (BG).…”

Data Sheet 9_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... by Alessandro Colletta (1509928)

“…Secondary outcomes included LS changes measured via TE and ARFI. Additional end points included MELD-Na, MELD 3.0, CTP scores, hepatic decompensations, proteinuria, body mass index (BMI), hemoglobin A1c (Hb-A1c), blood glucose (BG).…”

Data Sheet 4_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... by Alessandro Colletta (1509928)

“…Secondary outcomes included LS changes measured via TE and ARFI. Additional end points included MELD-Na, MELD 3.0, CTP scores, hepatic decompensations, proteinuria, body mass index (BMI), hemoglobin A1c (Hb-A1c), blood glucose (BG).…”

Data Sheet 7_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... by Alessandro Colletta (1509928)

“…Secondary outcomes included LS changes measured via TE and ARFI. Additional end points included MELD-Na, MELD 3.0, CTP scores, hepatic decompensations, proteinuria, body mass index (BMI), hemoglobin A1c (Hb-A1c), blood glucose (BG).…”